Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CNSX:ATT NYSEARCA:EWG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/AEWGiShares MSCI Germany ETF$40.98-1.3%$42.37$37.97▼$44.65$1.40B0.952.11 million shs1.12 million shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%EWGiShares MSCI Germany ETF+0.05%-0.72%-3.19%+6.65%+2.97%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/AEWGiShares MSCI Germany ETF$40.98-1.3%$42.37$37.97▼$44.65$1.40B0.952.11 million shs1.12 million shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%EWGiShares MSCI Germany ETF+0.05%-0.72%-3.19%+6.65%+2.97%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATTAbattis Bioceuticals 0.00N/AN/AN/AEWGiShares MSCI Germany ETF 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AEWGiShares MSCI Germany ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AN/AN/AN/AEWGiShares MSCI Germany ETFN/AN/A17.79N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthATTAbattis BioceuticalsN/AN/AN/AN/AN/AEWGiShares MSCI Germany ETF$0.832.03%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATTAbattis BioceuticalsN/AEWGiShares MSCI Germany ETF53.42%Insider OwnershipCompanyInsider OwnershipATTAbattis BioceuticalsN/AEWGiShares MSCI Germany ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATTAbattis BioceuticalsN/AN/AN/ANot OptionableEWGiShares MSCI Germany ETFN/A34.20 millionN/ANot OptionableEWG, QLT, MNKS, and ATT HeadlinesRecent News About These CompaniesGerman industry employment falls to ten-year low, study showsJune 17, 2026 | reuters.comGerman Investor Confidence Jumps on Hopes of End to Middle East ConflictJune 16, 2026 | wsj.comiShares MSCI Germany ETF declares semi-annual distribution of $0.831581June 15, 2026 | msn.comECB hikes interest rates for first time since 2023 as Iran war ramps-up energy costsJune 11, 2026 | cnbc.comThe ECB became the first major central bank to raise rates to tackle a war-driven resurgence in inflationJune 11, 2026 | wsj.comDAX, CAC 40, IBEX, and Stoxx 50 in focus ahead of the ECB interest rate decisionJune 11, 2026 | invezz.comIGermany faces €1 billion extra cost as EU allows wider industry power reliefJune 9, 2026 | reuters.comGerman, French leaders unable to resolve FCAS fighter jet dispute, sources sayJune 8, 2026 | reuters.comWeek Ahead for FX, Bonds: U.S. Inflation Data Due, ECB Likely to Raise RatesJune 5, 2026 | wsj.comEurozone Economy Shrank in First Quarter as Iran War Darkens Outlook AheadJune 5, 2026 | wsj.comTime to nip inflation in the bud: Five questions for the ECBJune 5, 2026 | reuters.comEU delays bank risk capital framework by three years, awaiting US, standardsJune 4, 2026 | reuters.comEurozone Retail Sales Fell in AprilJune 4, 2026 | wsj.comEU could lose 1.3 million jobs due to energy price surge linked to Iran war, Commission saysJune 3, 2026 | reuters.comFTSE 100 rises as mining stocks rally on stronger metal pricesJune 2, 2026 | invezz.comIEuropean markets edge down as geopolitical risks weighJune 1, 2026 | invezz.comIEWG: A Cautiously Optimistic Stance On German Equities Seems SensibleMay 28, 2026 | seekingalpha.comECB's decision to hold rates was close call for some, accounts showMay 28, 2026 | reuters.comGerman-Dutch corps to lead NATO land forces in Estonia and LatviaMay 28, 2026 | reuters.comEuropean stocks set to open lower following U.S. strikes on Iran, mixed messages on peace talksMay 26, 2026 | cnbc.comNew MarketBeat Followers Over TimeEWG, QLT, MNKS, and ATT Company DescriptionsAbattis Bioceuticals CNSX:ATTAbattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.iShares MSCI Germany ETF NYSEARCA:EWG$40.98 -0.56 (-1.35%) As of 05:19 PM EasterniShares MSCI Germany ETF, formerly iShares MSCI Germany Index Fund (the Fund), is an exchange-traded fund. The Fund seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of publicly traded securities in the German market, as measured by the MSCI Germany Index (the Index). The Index seeks to measure the performance of the Germany equity market. It is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. The Fund invests in sectors, such as consumer discretionary, financials, materials, industrials, healthcare, information technology, utilities, telecommunication services and consumer staples. BlackRock Fund Advisors (BFA) serves as the investment adviser to the Fund. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning These AI Stocks Have Insider Selling, But Buyers Still Have a Reason to Stay Apple’s Intel Deal Arrives at the Right Time for Its Stock Micron’s Sudden Plunge May Be an AI Buying Chance Amazon’s Pullback Deepens as a New FTC Risk Hits the Stock The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. How Does D-Wave's New Simulator Change the Quantum Computing Landscape? How Intel Is Packaging the Future of American Chips Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
